Modafinil-induced hippocampal activation in narcolepsy

Neuroscience Letters

Volumn 422, Issue 2, 2007, Pages 91-96

  Kim, Yu Kyeong ^a   Yoon, In Young ^a   Shin, Yoon Kyung ^a   Cho, Sang Soo ^a   Kim, Sang Eun ^a  

^a Seoul National University Bundang Hospital   (South Korea)

Author keywords

F 18 FDG PET; Hippocampus; Modafinil; Narcolepsy

Indexed keywords

FLUORODEOXYGLUCOSE F 18; MODAFINIL;

ADOLESCENT; ADULT; ARTICLE; BRAIN METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GLUCOSE METABOLISM; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS; LEFT HEMISPHERE; MALE; NARCOLEPSY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SLEEP WAKING CYCLE; STUDENT T TEST; THALAMUS; TREATMENT DURATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BENZHYDRYL COMPOUNDS; BRAIN MAPPING; BRAIN STEM; CENTRAL NERVOUS SYSTEM STIMULANTS; ENERGY METABOLISM; FEMALE; FLUORODEOXYGLUCOSE F18; FUNCTIONAL LATERALITY; GLUCOSE; HIPPOCAMPUS; HUMANS; HYPOTHALAMUS; MALE; NARCOLEPSY; NEURAL PATHWAYS; POSITRON-EMISSION TOMOGRAPHY; SLEEP; THALAMUS; TREATMENT OUTCOME; WAKEFULNESS;

EID: 34447512534     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.04.085     Document Type: Article

References (30)

1. American Academy of Sleep Medicine. The International Classification of Sleep Disorders: Diagnostic and Coding Manual. second ed. (2005), American Academy of Sleep Medicine, Westchester p. 293
2. Chemelli R.M., Willie J.T., Sinton C.M., Elmquist J.K., Scammell T., Lee C., Richardson J.A., Williams S.C., Xiong Y., Kisanuki Y., Fitch T.E., Nakazato M., Hammer R.E., Saper C.B., and Yanagisawa M. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98 (1999) 437-451
3. Chrobak J.J., and Buzsaki G. Selective activation of deep layer (V-VI) retrohippocampal cortical neurons during hippocampal sharp waves in the behaving rat. J. Neurosci. 14 (1994) 6160-6170
4. Chugani H.T. A critical period of brain development: studies of cerebral glucose utilization with PET. Prev. Med. 27 (1998) 184-188
5. Chugani H.T., Phelps M.E., and Mazziotta J.C. Positron emission tomography study of human brain functional development. Ann. Neurol. 22 (1987) 487-497
6. Draganski B., Geisler P., Hajak G., Schuierer G., Bogdahn U., Winkler J., and May A. Hypothalamic gray matter changes in narcoleptic patients. Nat. Med. 8 (2002) 1186-1188
7. Engber T.M., Dennis S.A., Jones B.E., Miller M.S., and Contreras P.C. Brain regional substrates for the actions of the novel wake-promoting agent modafinil in the rat: comparison with amphetamine. Neuroscience 87 (1998) 905-911
8. Ferraro L., Antonelli T., O'Connor W.T., Tanganelli S., Rambert F., and Fuxe K. The antinarcoleptic drug modafinil increases glutamate release in thalamic areas and hippocampus. Neuroreport 8 (1997) 2883-2887
9. Gallopin T., Luppi P.H., Rambert F.A., Frydman A., and Fort P. Effect of the wake-promoting agent modafinil on sleep-promoting neurons from the ventrolateral preoptic nucleus: an in vitro pharmacologic study. Sleep 27 (2004) 19-25
10. Jacobs B., Chugani H.T., Allada V., Chen S., Phelps M.E., Pollack D.B., and Raleigh M.J. Developmental changes in brain metabolism in sedated rhesus macaques and vervet monkeys revealed by positron emission tomography. Cereb. Cortex 5 (1995) 222-233
11. Ji D., and Wilson M.A. Coordinated memory replay in the visual cortex and hippocampus during sleep. Nat. Neurosci. 10 (2007) 100-107
12. Jones B.E. Brain Mechanism of Sleep-Wake States, Principles and Practice of Sleep Medicine (2005), Elsevier Saunders, Philadelphia p. 136
13. Joo E.Y., Hong S.B., Tae W.S., Kim J.H., Han S.J., Cho Y.W., Yoon C.H., Lee S.I., Lee M.H., Lee K.H., Kim M.H., Kim B.T., and Kim L. Cerebral perfusion abnormality in narcolepsy with cataplexy. Neuroimage 28 (2005) 410-416
14. Joo E.Y., Tae W.S., Kim J.H., Kim B.T., and Hong S.B. Glucose hypometabolism of hypothalamus and thalamus in narcolepsy. Ann. Neurol. 56 (2004) 437-440
15. Kaufmann C., Schuld A., Pollmacher T., and Auer D.P. Reduced cortical gray matter in narcolepsy: preliminary findings with voxel-based morphometry. Neurology 58 (2002) 1852-1855
16. Lin J.S., Hou Y., and Jouvet M. Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 14128-14133
17. Mata M., Fink D.J., Gainer H., Smith C.B., Davidsen L., Savaki H., Schwartz W.J., and Sokoloff L. Activity-dependent energy metabolism in rat posterior pituitary primarily reflects sodium pump activity. J. Neurochem. 34 (1980) 213-215
18. Mieda M., and Yanagisawa M. Sleep, feeding, and neuropeptides: roles of orexins and orexin receptors. Curr. Opin. Neurobiol. 12 (2002) 339-345
19. Mignot E., Lammers G.J., Ripley B., Okun M., Nevsimalova S., Overeem S., Vankova J., Black J., Harsh J., Bassetti C., Schrader H., and Nishino S. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch. Neurol. 59 (2002) 1553-1562
20. Nishino S., and Mignot E. Wake-Promoting Medications: Basic Mechanisms and Pharmacology, Principles and Practice of Sleep Medicine (2005), Elsevier Saunders, Philadelphia p. 468
21. Nishino S., Ripley B., Overeem S., Lammers G.J., and Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355 (2000) 39-40
22. Overeem S., Steens S.C., Good C.D., Ferrari M.D., Mignot E., Frackowiak R.S., van Buchem M.A., and Lammers G.J. Voxel-based morphometry in hypocretin-deficient narcolepsy. Sleep 26 (2003) 44-46
23. Saletu M., Anderer P., Saletu-Zyhlarz G.M., Mandl M., Arnold O., Zeitlhofer J., and Saletu B. EEG-tomographic studies with LORETA on vigilance differences between narcolepsy patients and controls and subsequent double-blind, placebo-controlled studies with modafinil. J. Neurol. 251 (2004) 1354-1363
24. Scammell T.E. The neurobiology, diagnosis, and treatment of narcolepsy. Ann. Neurol. 53 (2003) 154-166
25. Scammell T.E., Estabrooke I.V., McCarthy M.T., Chemelli R.M., Yanagisawa M., Miller M.S., and Saper C.B. Hypothalamic arousal regions are activated during modafinil-induced wakefulness. J. Neurosci. 20 (2000) 8620-8628
26. Taheri S., Zeitzer J.M., and Mignot E. The role of hypocretins (orexins) in sleep regulation and narcolepsy. Annu. Rev. Neurosci. 25 (2002) 283-313
27. Talairach J., and Touernoux P. Co-Planar Stereotaxic Atlas of the Human Brain: 3-Dimensional Proportional System: An Approach to Cerebral Imaging (1988), Thieme, New York
28. Thannickal T.C., Moore R.Y., Nienhuis R., Ramanathan L., Gulyani S., Aldrich M., Cornford M., and Siegel J.M. Reduced number of hypocretin neurons in human narcolepsy. Neuron 27 (2000) 469-474
29. Ware Jr. J.E., and Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med. Care. 30 (1992) 473-483
30. Wu M., Zhang Z., Leranth C., Xu C., van den Pol A.N., and Alreja M. Hypocretin increases impulse flow in the septohippocampal GABAergic pathway: implications for arousal via a mechanism of hippocampal disinhibition. J. Neurosci. 22 (2002) 7754-7765